Page last updated: 2024-08-26

fotemustine and Chromosome Deletion

fotemustine has been researched along with Chromosome Deletion in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Branle, F; Camby, I; Geurts-Moespot, A; Jeuken, J; Kiss, R; Lefranc, F; Salmon, I; Sprenger, S; Sweep, F	1
Ashby, J; Callander, RD; Shuker, DE; Tinwell, H; Vogel, EW	1

Other Studies

2 other study(ies) available for fotemustine and Chromosome Deletion

Article	Year
Evaluation of the efficiency of chemotherapy in in vivo orthotopic models of human glioma cells with and without 1p19q deletions and in C6 rat orthotopic allografts serving for the evaluation of surgery combined with chemotherapy. Cancer, 2002, Aug-01, Volume: 95, Issue:3 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Chromosome Deletion; Chromosomes, Human, Pair 1; Combined Modality Therapy; Dacarbazine; DNA Fingerprinting; DNA, Neoplasm; Glioma; Glutathione Transferase; Humans; Immunohistochemistry; Intermediate Filament Proteins; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Nude; Middle Aged; Neoplasm Transplantation; Neoplasms, Experimental; Nerve Tissue Proteins; Nestin; Nitrosourea Compounds; Nucleic Acid Hybridization; Organophosphorus Compounds; Rats; Rats, Sprague-Dawley; Survival Analysis; Temozolomide; Treatment Outcome; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Vimentin; Xenograft Model Antitumor Assays	2002
Mutagenicity to Salmonella, Drosophila and the mouse bone marrow of the human antineoplastic agent fotemustine: prediction of carcinogenic potency. Mutation research, 1993, Volume: 286, Issue:1 Topics: Animals; Antineoplastic Agents; Biological Assay; Bone Marrow; Carcinogenicity Tests; Carcinogens; Chromosome Deletion; Dose-Response Relationship, Drug; Drosophila melanogaster; Female; Male; Mice; Micronucleus Tests; Mutagenicity Tests; Mutagens; Nitrosourea Compounds; Organophosphorus Compounds; Predictive Value of Tests; Salmonella typhimurium; Semustine; X Chromosome	1993

Article

Year

Evaluation of the efficiency of chemotherapy in in vivo orthotopic models of human glioma cells with and without 1p19q deletions and in C6 rat orthotopic allografts serving for the evaluation of surgery combined with chemotherapy.

Cancer, 2002, Aug-01, Volume: 95, Issue:3

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Chromosome Deletion; Chromosomes, Human, Pair 1; Combined Modality Therapy; Dacarbazine; DNA Fingerprinting; DNA, Neoplasm; Glioma; Glutathione Transferase; Humans; Immunohistochemistry; Intermediate Filament Proteins; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Nude; Middle Aged; Neoplasm Transplantation; Neoplasms, Experimental; Nerve Tissue Proteins; Nestin; Nitrosourea Compounds; Nucleic Acid Hybridization; Organophosphorus Compounds; Rats; Rats, Sprague-Dawley; Survival Analysis; Temozolomide; Treatment Outcome; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Vimentin; Xenograft Model Antitumor Assays

2002

Mutagenicity to Salmonella, Drosophila and the mouse bone marrow of the human antineoplastic agent fotemustine: prediction of carcinogenic potency.

Mutation research, 1993, Volume: 286, Issue:1

Topics: Animals; Antineoplastic Agents; Biological Assay; Bone Marrow; Carcinogenicity Tests; Carcinogens; Chromosome Deletion; Dose-Response Relationship, Drug; Drosophila melanogaster; Female; Male; Mice; Micronucleus Tests; Mutagenicity Tests; Mutagens; Nitrosourea Compounds; Organophosphorus Compounds; Predictive Value of Tests; Salmonella typhimurium; Semustine; X Chromosome

1993